LISATA THERAPEUTICS, INC. Buildings and Improvements, Gross
LISATA THERAPEUTICS, INC. (LSTA) had Buildings and Improvements, Gross of $12.97 million as of 2016-12-31, per its 10-K filed 2017-03-17.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:BuildingsAndImprovementsGross · last filed 2017-03-17
- 2016-12-31: Buildings and Improvements, Gross $12.97M.
- 2015-12-31: Buildings and Improvements, Gross $11.48M.
- 2014-12-31: Buildings and Improvements, Gross $11.30M.
- 2013-12-31: Buildings and Improvements, Gross $11.23M.
| Period end | Buildings and Improvements, Gross |
|---|---|
| 2016-12-31 | $12.97M 10-K · filed 2017-03-17 |
| 2015-12-31 | $11.48M 10-K · filed 2017-03-17 |
| 2014-12-31 | $11.30M 10-K · filed 2016-03-15 |
| 2013-12-31 | $11.23M 10-K · filed 2015-03-02 |
| 2012-12-31 | $9.90M 10-K · filed 2014-03-13 |
| 2011-12-31 | $9.87M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |